Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: RADIATION: [F18]CP-18 Injection
Sponsor: Siemens Molecular Imaging